November 23, 2016 - By Peter Erickson · 0 Comments
The stock of Akers Biosciences Incorporated (NASDAQ:AKER) registered a decrease of 78.61% in short interest. AKER’s total short interest was 3,700 shares in November as published by FINRA. Its down 78.61% from 17,300 shares, reported previously. With 10,100 shares average volume, it will take short sellers 0 days to cover their AKER’s short positions. The short interest to Akers Biosciences Incorporated’s float is 0.1%. About 180,245 shares traded hands or 289.95% up from the average. Akers Biosciences Inc (NASDAQ:AKER) has risen 33.06% since April 21, 2016 and is uptrending. It has outperformed by 27.73% the S&P500.
More news for Akers Biosciences Inc (NASDAQ:AKER) were recently published by: Quotes.Wsj.com, which released: “News Akers Biosciences Inc.AKER” on January 24, 2014. Marketwatch.com‘s article titled: “Akers Biosciences halves loss; revenue up 262%” and published on November 14, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Peter Erickson